Age, sex, smoking history, positive RF, and anti-CCP, along with a combinatorial signature of serum biomarkers, including MMP-7, pulmonary and activation-regulated chemokine (PARC), and SP-D, could predict RA-ILD [113]. This evidence concerns the gene CCL18 and interstitial lung disease.